aspirin

Biz Brief: Stroke Drug Study Ends Early on Positive Result

Pfizer and Bristol-Myers Squibb said on Thursday that they've decided to halt a clinical trial several months early because data so far suggested the experimental drug apixaban was more effective than aspirin in preventing strokes among patients.